Summary & Overview
CPT 36470: Sclerotherapy Injection for Varicose Vein
CPT code 36470 denotes sclerotherapy involving injection of a sclerosing solution into a single vein, most often used to treat varicose veins and some vascular malformations (excluding telangiectasia). Nationally, this procedure is a common, minimally invasive option in vascular and phlebology care pathways and has implications for ambulatory care utilization and outpatient procedural billing.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context, typical sites of service, and the common payer landscape affecting coverage and claims processing. The publication summarizes national benchmarks where available, highlights relevant policy and coding considerations related to outpatient procedural billing, and outlines the clinical scenarios in which 36470 is applied.
This analysis is intended for billing professionals, practice managers, and clinicians seeking a concise reference on the clinical purpose and payer context of CPT code 36470. Data not provided in the input are noted as unavailable; the focus remains on clinical description, service setting, and the payers commonly involved in coverage and reimbursement decisions.
Billing Code Overview
CPT code 36470 describes injection of a sclerosing solution into a single vein, most commonly performed to treat a varicose vein. The procedure targets abnormal venous segments and may be used for other vascular malformations except for spider veins (telangiectasia).
Service Type: Sclerotherapy — percutaneous vein injection
Typical Site of Service: Outpatient clinic, physician office, or ambulatory surgical center
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 52-year-old ambulatory adult presenting to an outpatient vascular clinic with a symptomatic varicose vein of the lower extremity causing aching, swelling, and cosmetic concern. The patient has had duplex ultrasound confirming reflux in a single incompetent superficial vein segment appropriate for sclerotherapy. The procedure is scheduled in an office-based procedure room or ambulatory surgery center. The provider obtains informed consent, documents indications and prior conservative care (compression, leg elevation), and confirms no contraindications (active infection, allergy to sclerosant, pregnancy). Under ultrasound guidance or direct visualization, the provider injects a sclerosing solution into the targeted vein (CPT 36470) using sterile technique. Post-procedure care includes compression dressing, ambulation instructions, and follow-up arranged for assessment of efficacy and complications such as phlebitis or thrombosis. Billing reflects a single vein treated under CPT 36470 with relevant modifier use documented when applicable.
Coding Specifications
- Use the table below for the most clinically relevant modifiers for sclerotherapy (
CPT36470).
| Modifier | Description |
|---|